UNSPSC 51293603: Amedalin hydrochloride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OWK6X9N16. European Medicines Agency schedules Amedalin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05406MIG. Amedalin generally arises in the molecular formula C19H22N2O.

UNSPSC 51293603 Amedalin hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local procurement activity tagged under this code does not reflect purchases of amedalin hydrochloride itself. Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) solicits naloxone and safe drug deactivation systems—naloxone being a different opioid antagonist used in overdose reversal—in quantities of 1,900 units annually, with quarterly deliveries to the Seminole County Community Health Building. The mismatch between the code's nominal scope and the actual solicitation suggests either a data-entry error in the tagging or a platform classification issue. State and local procurement records show no other recent opportunities under this code.

Given the absence of recent activity aligned with the code's actual commodity definition and the single representative opportunity's documented misalignment, this code shows little relevant recent purchasing activity in the state and local market. Firms evaluating pursuit should confirm whether the underlying procurement need is for amedalin hydrochloride specifically or whether related opioid-antagonist or drug-deactivation products better align with Seminole County's stated scope. The Seminole County opportunity itself—if naloxone supply is the target—may be better tracked under a general pharmaceutical or medical-supply code rather than under this chemical-specific designation.